Commentary

Video

Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews interactive learning and innovation amid winter fun

Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, all set against the backdrop of Snowmass, Colorado.

The 2025 Snowmass Retina and Eye Meeting, scheduled from March 24 to 28 in Snowmass, Colorado, will provide ophthalmologist-attendees with a unique opportunity to combine advanced learning with winter recreation.

Ronald Frenkel, MD, Course Director, sat down with Ophthalmology Times to discuss the conference's dedication to cutting-edge advancements in ophthalmology, particularly retina and cataract, glaucoma, and the anterior segment. “We wanted to get an update on the latest things and the newest things in retina and in ophthalmology,” he explained, highlighting the meeting’s interactive format to maximize learning.

The agenda will include updates on drug-delivery platforms for glaucoma, MIGS, pseudoexfoliation, and presbyopia-correcting IOLs. Keynote speakers, such as Leon Herndon, MD, will deliver the Epstein Lecture on advanced glaucoma, and Cathleen McCabe, MD, will presenting the Ridley Lecture on cataract surgery. Retina-focused sessions will include David Sarraf, MD’s Machemer Lecture on reducing pigment epithelial detachment and retinal pigment epithelium tear risks, along with discussions on breakthroughs in macular disease and geographic atrophy treatments. “We’re real current on that,” Frenkel noted. Additionally, artificial intelligence will be a key theme, with talks on AI’s role in diabetic retinopathy and panel discussions that encourage active audience participation. “Your voice and your questions will be heard,” he emphasized.

The event will cater to a wide-ranging audience, including retina specialists, comprehensive ophthalmologists, and glaucoma or cataract surgeons. Attendees can customize their experience by selecting program segments of interest. The schedule will include seven-hour daily breaks for activities, such as skiing, fostering informal yet valuable networking opportunities. “I’ve learned a lot of great things just on the chair lift,” Frenkel added.

With its new venue at the Viceroy Hotel, this 15th annual meeting will continue its tradition of deep engagement. “We’ve tried to hit really important topics and update those topics by just all-star faculty,” Frenkel concluded.

To learn more about or to register for Snowmass Retina & Eye 2025, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.